Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · BNY Mellon / Dreyfus

BNY Mellon Small/Mid Cap Growth Fund Class C (DBMCX)

Ticker DBMCX · · Holdings as of Jun 30, 2026

Expense ratio
1.86%$186/yr per $10k
5-yr return
−3.0%annualized
1-yr return
+9.7%as of Dec 2025
Net assets
$867.6Mall share classes
Holdings
76

Bottom line

Is DBMCX a good fund? The bottom line

DBMCX is the Class C share class of BNY Mellon Small/Mid Cap Growth Fund, a managed mid-cap mutual fund from BNY Mellon / Dreyfus.

Its expense ratio is 1.86% — about $186 a year on every $10,000 invested, more expensive than 93% of mid-cap funds we track.

It returned +9.7% over one year, −3.0% a year over five years, +10.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $868 million in net assets and 76 holdings, its largest position is Repligen Corp (3.4%) and the top 10 make up 29.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.86%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.75% a year
  • High turnover (131% a year) can mean more taxable distributions

Updated Nov 19, 2026

What DBMCX invests in

The fund seeks long-term growth of capital.

To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap and mid-cap U.S. companies. The fund currently considers small-cap and mid-cap companies to be those companies with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell Midcap Index (the Index). As of December 31, 2025, the market capitalization of the largest company in the Index was approximately $101 billion. The fund's sub-adviser, Newton Investment Management North America, LLC, an affiliate of BNY Mellon Investment Adviser, Inc., employs a growth-oriented investment style in managing the fund's portfolio, which means the sub-adviser seeks to identify those small-cap and mid-cap companies which are experiencing or are expected to experience…

From the fund's prospectus (filed Jul 31, 2026).

DBMCX performance

Average annual total returns
1 yr5 yr10 yr
DBMCX+9.7%−3.0%+10.2%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full DBMCX performance history →

What DBMCX costs

On a $10,000 investment, DBMCX's 1.86% expense ratio costs about $186 a year. The prospectus estimates $2,180 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full DBMCX fee table →

DBMCX top 10 holdings

#Holding% of fund
1Repligen Corp RGEN3.45%
2Baldwin Insurance Group Inc (the) BWIN3.23%
3Guardant Health Inc GH3.20%
4Construction Partners Inc ROAD3.17%
5Casey's General Stores Inc CASY2.91%
6Bel Fuse Inc BELFB2.89%
7Regal Rexnord Corp RRX2.78%
8Wingstop Inc WING2.64%
9Curtiss-wright Corp CW2.63%
10Herc Holdings Inc HRI2.58%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 29.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to DBMCX

More funds like DBMCX →

DBMCX FAQ

What is the expense ratio of DBMCX?
DBMCX's expense ratio is 1.86%, which works out to about $186 a year for every $10,000 invested. The prospectus estimates total costs of $2,180 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DBMCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.86%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.75% a year; high turnover (131% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does DBMCX hold?
DBMCX's largest holdings are Repligen Corp (3.4%), Baldwin Insurance Group Inc (the) (3.2%), Guardant Health Inc (3.2%), Construction Partners Inc (3.2%), Casey's General Stores Inc (2.9%). It holds 76 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is DBMCX's 5-year return?
DBMCX returned −3.0% a year over the five years ending Dec 31, 2025, and +10.2% a year over ten years. Past performance does not guarantee future results.
Does DBMCX have a sales load?
No. DBMCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages DBMCX?
DBMCX is offered by BNY Mellon / Dreyfus through BNY Mellon Investment Funds I.